Henry Schein's 2025 Outlook Hinges On Strong Second-Half Execution

Henry Schein Inc. reported mixed Q2 results, with adjusted EPS of $1.10 missing consensus estimates of $1.20, while revenue of $3.24 billion exceeded expectations, leading to an 8.80% stock decline. The company affirmed its 2025 guidance and anticipates over $100 million in annual savings from restructuring by year-end 2025. Management also provided informal 2026 guidance for high-single to low-double-digit EPS growth, driven by ongoing efficiency initiatives and a new partnership with KKR Capstone aimed at enhancing margins.

Analysis

Henry Schein Inc. (HSIC) reported mixed second-quarter results, characterized by a significant earnings miss but a slight revenue beat, prompting a sharp negative market reaction. The company's adjusted EPS of $1.10 fell 10.6% year-over-year and missed the $1.20 consensus estimate, driving an 8.8% decline in its stock price. Conversely, revenue grew 3.3% to $3.24 billion, narrowly exceeding expectations. The revenue growth was underpinned by strong performance in the Global Technology segment, which saw a 7.4% increase driven by cloud-based solutions, and resilient international dental equipment sales. A slowdown in US dental equipment orders in May, attributed to tariff uncertainty, was noted as temporary and reportedly normalized by the end of the quarter. Looking forward, management has affirmed its full-year 2025 guidance for both EPS and revenue, signaling confidence despite the quarterly shortfall. Furthermore, the company announced a restructuring plan, including a partnership with KKR Capstone, which is expected to generate over $100 million in annual run-rate savings by the end of 2025. This initiative supports an informal 2026 forecast for high-single to low-double-digit EPS growth, an outlook described by analysts as a 'welcome update' against an 8% consensus.

Key Decisions for Investors

• Investors should assess whether the 8.8% stock price decline is an overreaction to the Q2 EPS miss, given that management affirmed full-year 2025 guidance and provided a positive informal outlook for 2026.
• Monitor the progress of the company's restructuring and partnership with KKR Capstone, as the realization of the projected $100 million in annual savings is a critical catalyst for achieving future earnings growth targets.
• Scrutinize upcoming reports for continued momentum in the high-growth Global Technology segment and for confirmation that the US dental equipment sales have fully recovered from the temporary Q2 slowdown.
• Consider the current price weakness as a potential entry point for a long-term position, contingent on confidence in management's ability to execute on its margin improvement strategy and translate it into the guided 2026 EPS growth.